Vistagen Therapeutics, Inc. · NASDAQ:VTGN
The Vanguard Group's stake in Vistagen Therapeutics, Inc. fell to 4.62% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Vistagen Therapeutics, Inc. fell to 4.62%, 1,824,738 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.62%
- Shares
- 1,824,738
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.62% | 1,824,738 |
Source
Related
- Vistagen Therapeutics, Inc.
- The Vanguard Group
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Oct 31, 2025
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026